Beta-adrenergic receptor blockers in tablet form for hypertension management. Pharmaceutical manufacturers produce these for supply chains serving hospitals, outpatient clinics, and retail pharmacies. Healthcare procurement teams acquire them for cardiovascular treatment protocols in primary care and specialty facilities.